EFMH
WST icon

E Fund Management (HK)’s West Pharmaceutical WST Stock Holding History

E Fund Management (HK)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Buy
+30
New +$9.17K ﹤0.01% 417

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

E Fund Management (HK)'s WST Position: Q2 2026 in Review

E Fund Management (HK) opened a new position in West Pharmaceutical (WST) in Q2 2026: 30 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #417 among its holdings.

252 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • E Fund Management (HK) held 30 shares of West Pharmaceutical worth $10.8K as of Q2 2026.
  • West Pharmaceutical was a new E Fund Management (HK) position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #417 holding.
  • 252 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.